Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial
Taken together, our findings indicate that the treatment with a NUT combination containing Morus alba simultaneously reduces plasma levels of LDL-C and glucose.
Authors
- Francesco Rozza (ORCID: https://orcid.org/0000-0002-6631-6230)
- Carmine Morisco (ORCID: https://orcid.org/0000-0002-2158-6317)
- Gaetano Santulli (ORCID: https://orcid.org/0000-0001-7231-375X)
- Eliana Pia Esposito (ORCID: https://orcid.org/0000-0001-8872-4211)
- Daniela Pacella (ORCID: https://orcid.org/0000-0003-2343-5069)
- Maria Virginia Manzi (ORCID: https://orcid.org/0000-0002-1979-7131)
- Stefano Cristiano (ORCID: https://orcid.org/0009-0001-6096-2768)
- Stanislovas S. Jankauskas (ORCID: https://orcid.org/0000-0002-0843-5098)
- Giuseppe Giugliano (ORCID: https://orcid.org/0000-0002-1467-1687)
- Alessandra Spinelli (ORCID: https://orcid.org/0009-0001-6058-4912)
- Maria Lembo (ORCID: https://orcid.org/0000-0001-6454-2560)
- Sun King B. Bear
- Antonio Izzo (ORCID: https://orcid.org/0000-0001-5018-3835)
- Paola Gallo
- Imma Forzano
- L. Esposito (ORCID: https://orcid.org/0000-0003-3392-2469)
- Valentina Trimarco (ORCID: https://orcid.org/0000-0001-5869-2247)
- Paola Ida Rozza
Institutions
- Albert Einstein College of Medicine (US)
- Feinstein Institute for Medical Research (US)
- Hodges University (US)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Federico II University Hospital (IT)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1186/s12933-025-02920-4
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00